Astellas Pharma's total assets for Q3 2024 were ¥3.45T, a decrease of -0.31% from the previous quarter. ALPMF total liabilities were ¥1.96T for the fiscal quarter, a 1.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.